These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15211608)

  • 1. Adaptive urn designs for estimating several percentiles of a dose--response curve.
    Mugno R; Zhus W; Rosenberger WF
    Stat Med; 2004 Jul; 23(13):2137-50. PubMed ID: 15211608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of adaptive allocation rules for group-sequential binary response clinical trials.
    Morgan CC; Stephen Coad D
    Stat Med; 2007 Apr; 26(9):1937-54. PubMed ID: 16981177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptive designs for dose-finding in non-cancer phase II trials: influence of early unexpected outcomes.
    Resche-Rigon M; Zohar S; Chevret S
    Clin Trials; 2008; 5(6):595-606. PubMed ID: 19029208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal adaptive design in clinical drug development: a simulation example.
    Maloney A; Karlsson MO; Simonsson US
    J Clin Pharmacol; 2007 Oct; 47(10):1231-43. PubMed ID: 17906158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple-objective designs in a dose-response experiment.
    Zhu W; Wong WK
    J Biopharm Stat; 2000 Feb; 10(1):1-14. PubMed ID: 10709797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient design for estimation of median lethal dose and quantal dose-response curves.
    Kalish LA
    Biometrics; 1990 Sep; 46(3):737-48. PubMed ID: 2242412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian optimal designs for estimating a set of symmetrical quantiles.
    Zhu W; Kee Wong W
    Stat Med; 2001 Jan; 20(1):123-137. PubMed ID: 11135352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal dose-finding designs with correlated continuous and discrete responses.
    Fedorov V; Wu Y; Zhang R
    Stat Med; 2012 Feb; 31(3):217-34. PubMed ID: 22162014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential urn designs with elimination for comparing K > or =3 treatments.
    Coad DS; Ivanova A
    Stat Med; 2005 Jul; 24(13):1995-2009. PubMed ID: 15803441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An adaptive phase I design for identifying a biologically optimal dose for dual agent drug combinations.
    Mandrekar SJ; Cui Y; Sargent DJ
    Stat Med; 2007 May; 26(11):2317-30. PubMed ID: 17016867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choice of number of doses for maximum likelihood estimation of the ED50 for quantal dose-response data.
    Müller HG; Schmitt T
    Biometrics; 1990 Mar; 46(1):117-29. PubMed ID: 2350566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal designs for estimating the most successful dose.
    Zohar S; O'Quigley J
    Stat Med; 2006 Dec; 25(24):4311-20. PubMed ID: 16969893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the efficiency of two-stage response-adaptive designs.
    Dette H; Bornkamp B; Bretz F
    Stat Med; 2013 May; 32(10):1646-60. PubMed ID: 22865374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal and minimax three-stage designs for phase II oncology clinical trials.
    Chen K; Shan M
    Contemp Clin Trials; 2008 Jan; 29(1):32-41. PubMed ID: 17544337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptive Dc-optimal designs for dose finding based on a continuous efficacy endpoint.
    Padmanabhan SK; Dragalin V
    Biom J; 2010 Dec; 52(6):836-52. PubMed ID: 20891026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dose-cohort designs in cancer phase I trials.
    Huang B; Chappell R
    Stat Med; 2008 May; 27(12):2070-93. PubMed ID: 17764082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining proof-of-concept with dose-finding: utilization of adaptive designs in migraine clinical trials.
    Sagkriotis A; Scholpp J
    Cephalalgia; 2008 Aug; 28(8):805-12. PubMed ID: 18513264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-objective optimal experimental designs for event-related fMRI studies.
    Kao MH; Mandal A; Lazar N; Stufken J
    Neuroimage; 2009 Feb; 44(3):849-56. PubMed ID: 18948212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Closure procedures for monotone bi-factorial dose-response designs.
    Hellmich M; Lehmacher W
    Biometrics; 2005 Mar; 61(1):269-76. PubMed ID: 15737103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal designs for the individual and joint exposure general logistic regression models.
    Antonello JM; Raghavarao D
    J Biopharm Stat; 2000 Aug; 10(3):351-67. PubMed ID: 10959916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.